Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM507705
Substrate
n/a
Meas. Tech.
IRAK4 Biochemical Assay
IC50
<1.000±n/a nM
Citation
 Ammann, SBacon, EMBrizgys, GChin, EChou, CCottell, JJNdukwe, MShatskikh, MTaylor, JGWright, NEYang, ZZipfel, SM Thiadiazole IRAK4 compounds US Patent  US11046686 Publication Date 6/29/2021 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM507705
Synonyms:
N-((1r,4r)-4-(5-(6-(3- cyanopyrrolo[1,2- b]pyridazin-7-yl)-4- (methylamino)pyridin- 3-yl)-1,3,4-thiadiazol- 2- yl)cyclohexyl)acetamide | US11046686, Example 22
Type:
Small organic molecule
Emp. Form.:
C24H24N8OS
Mol. Mass.:
472.565
SMILES:
CNc1cc(ncc1-c1nnc(s1)[C@H]1CCC(CC1)NC(C)=O)-c1ccc2cc(cnn12)C#N |r,wU:13.14,(3.03,3.7,;1.7,2.93,;1.7,1.39,;3.03,.62,;3.03,-.92,;1.7,-1.69,;.36,-.92,;.36,.62,;-.97,1.39,;-.97,2.93,;-2.44,3.41,;-3.34,2.16,;-2.44,.92,;-4.83,1.76,;-5.23,.28,;-6.71,-.12,;-7.8,.97,;-7.4,2.45,;-5.92,2.85,;-9.29,.57,;-10.38,1.66,;-11.87,1.26,;-9.98,3.15,;4.36,-1.69,;4.36,-3.23,;5.83,-3.7,;6.73,-2.46,;8.27,-2.3,;8.89,-.89,;7.99,.36,;6.46,.2,;5.83,-1.21,;10.38,-.49,;11.87,-.09,)|
Structure:
Search PDB for entries with ligand similarity: